[1] |
SUNG H,, FERLAY J,, SIEGEL R L, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
[2] |
HUTCHINSON B D,, SHROFF G S,, TRUONG M T, et al.Spectrum of lung adenocarcinoma[J]. Semin Ultrasound CT MR, 2019, 40(3): 255-264.
|
[3] |
ETTINGER D S,, WOOD D E,, AISNER D L, et al.Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2017, 15(4): 504-535.
|
[4] |
OSMANI L,, ASKIN F,, GABRIELSON E, et al.Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy[J]. Semin Cancer Biol, 2018, 52(Pt 1): 103-109.
|
[5] |
XING P Y,, WANG S Z,, WANG Q, et al.Efficacy of crizotinib for advanced ALK-rearranged non-small cell lung cancer patients with brain metastasis: a multicenter, retrospective study in China[J]. Target Oncol, 2019, 14(3): 325-333.
|
[6] |
王晓莉,, 葛晓松,, 刘彦魁, 等. EGFR/ALK/ROS1三联检测在非小细胞肺癌中的临床意义[J]. 临床与实验病理学杂志, 2018, 34(10): 1135-1137.
|
|
WANG X L,, GE X S,, LIU Y K, et al.Clinical significance of EGFR/ALK/ros1 triple detection in non-small cell lung cancer[J]. Chin J Clin Exp Pathol, 2018, 34(10): 1135-1137.
|
[7] |
PARK J Y,, JANG S H.Epidemiology of lung cancer in Korea: recent trends[J]. Tuberc Respir Dis (Seoul), 2016, 79(2): 58-69.
|
[8] |
TESTA U,, CASTELLI G,, PELOSI E.Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells[J]. Cancers (Basel), 2018, 10(8): E248.
|
[9] |
CHANG S C,, LAI Y C,, CHEN Y C, et al.CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer[J]. Asia Pac J Clin Oncol, 2018, 14(5): e283-e288.
|
[10] |
CANZIO D,, LARSON A,, NARLIKAR G J.Mechanisms of functional promiscuity by HP1 proteins[J]. Trends Cell Biol, 2014, 24(6): 377-386.
|
[11] |
LOVE M I,, HUBER W,, ANDERS S.Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2[J]. Genome Biol, 2014, 15(12): 550.
|
[12] |
HÄNZELMANN S,, CASTELO R,, GUINNEY J. GSVA: gene set variation analysis for microarray and RNA-seq data[J]. BMC Bioinformatics, 2013, 14: 7.
|
[13] |
BINDEA G,, MLECNIK B,, TOSOLINI M, et al.Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer[J]. Immunity, 2013, 39(4): 782-795.
|
[14] |
CHALELA R,, CURULL V,, ENRÍQUEZ C, et al. Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy[J]. J Thorac Dis, 2017, 9(7): 2142-2158.
|
[15] |
IMAI H,, KAIRA K,, MINATO K.Clinical significance of post-progression survival in lung cancer[J]. Thorac Cancer, 2017, 8(5): 379-386.
|
[16] |
GREWAL S I,, JIA S.Heterochromatin revisited[J]. Nat Rev Genet, 2007, 8(1): 35-46.
|
[17] |
VAKOC C R,, MANDAT S A,, OLENCHOCK B A, et al.Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin[J]. Mol Cell, 2005, 19(3): 381-391.
|
[18] |
MATEESCU B,, BOURACHOT B,, RACHEZ C, et al.Regulation of an inducible promoter by an HP1beta-HP1gamma switch[J]. EMBO Rep, 2008, 9(3): 267-272.
|
[19] |
KWON S H,, WORKMAN J L.HP1c casts light on dark matter[J]. Cell Cycle, 2011, 10(4): 625-630.
|
[20] |
NONAKA N,, KITAJIMA T,, YOKOBAYASHI S, et al.Recruitment of cohesin to heterochromatic regions by Swi6/HP1 in fission yeast[J]. Nat Cell Biol, 2002, 4(1): 89-93.
|
[21] |
YAMAGISHI Y,, SAKUNO T,, SHIMURA M, et al.Author correction: heterochromatin links to centromeric protection by recruiting shugoshin[J]. Nature, 2018, 563(7730): E21.
|
[22] |
HAYAKAWA T,, HARAGUCHI T,, MASUMOTO H, et al.Cell cycle behavior of human HP1 subtypes: distinct molecular domains of HP1 are required for their centromeric localization during interphase and metaphase[J]. J Cell Sci, 2003, 116(Pt 16): 3327-3338.
|
[23] |
EGUCHI T,, CALDERWOOD S K,, TAKIGAWA M, et al.Intracellular MMP3 promotes HSP gene expression in collaboration with chromobox proteins[J]. J Cell Biochem, 2017, 118(1): 43-51.
|
[24] |
FAN Y,, LI H P,, LIANG X L, et al.CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle[J]. Oncotarget, 2017, 8(12): 19934-19946.
|
[25] |
WANG S Q,, LIU F,, WANG Y H, et al.Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma[J]. J Transl Med, 2019, 17(1): 179.
|
[26] |
HAN S S,, KIM W J,, HONG Y, et al.RNA sequencing identifies novel markers of non-small cell lung cancer[J]. Lung Cancer, 2014, 84(3): 229-235.
|
[27] |
LIU J,, ZHANG Y,, ZHAO J, et al.Mast cell: insight into remodeling a tumor microenvironment[J]. Cancer Metastasis Rev, 2011, 30(2): 177-184.
|
[28] |
HUANG B,, LEI Z,, ZHANG G M, et al.SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment[J]. Blood, 2008, 112(4): 1269-1279.
|